Hydroxyethyl starch 130/0.4 for volume replacement therapy in surgical patients: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: The safety of perioperative intravenous hydroxyethyl starch (HES) products, specifically HES 130/0.4, continues to be the source of much debate. The aim of this meta-analysis was to update the existing evidence and gain further insight into the clinical effects of HES 130/0.4 on postoper...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yi, Wang, Siying, He, Leilei, Yu, Hong, Yu, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111748/
https://www.ncbi.nlm.nih.gov/pubmed/33971968
http://dx.doi.org/10.1186/s13741-021-00182-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111748/
https://www.ncbi.nlm.nih.gov/pubmed/33971968
http://dx.doi.org/10.1186/s13741-021-00182-8

Ejemplares similares